Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / In8bio, Inc.

In8bio, Inc.

Stage unknownNew York, NYBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Dec 22, 2025
    Form D equity offering · $20.1M (form d sold) · 17 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “In8bio, Inc. filed Form D: $20,119,049 sold of $40,239,043, Biotechnology”
  2. Oct 4, 2024
    Form D equity offering · $12.4M (form d sold) · 73 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “In8bio, Inc. filed Form D: $12,379,983 sold of $12,379,983, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
4 officers, 7 directors
Timeline
2
  1. Dec 30, 2025
    In8bio, Inc. filed Form D: $20,119,049 sold of $40,239,043, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Oct 15, 2024
    In8bio, Inc. filed Form D: $12,379,983 sold of $12,379,983, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company